Clonidine and Brain Mitochondrial Energy Metabolism: Pharmacodynamic Insights Beyond Receptorial Effects
- 31 January 2022
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 47 (5) , 1429-1441
Abstract
Clonidine is an anti-hypertensive drug that inhibits the release of norepinephrine from pre-synaptic terminals binding to pre-synaptic α2-adrenoreceptors. Some studies suggest that this drug decreases brain energy expenditure, particularly in hypoxic-ischemic injury. However, data about clonidine effects on the functional parameters regulating brain energy metabolism are lacking. In this study, the effects of acute clonidine treatment (5 μg×kg−1 i.p., 30 min) were evaluated on the catalytic activity of regulatory energy-linked enzymes of Krebs’ cycle, Electron Transport Chain and glutamate metabolism of temporal cerebral cortex of 3-month-old male Sprague–Dawley rats. Enzyme activities were assayed on non-synaptic “free” mitochondria (FM) of neuronal perikaryon and partly of glial cells, and on intra-synaptic “light” (LM) and “heavy” mitochondria (HM), localized within synaptic terminals. This subcellular analysis differentiates clonidine effects on post-synaptic and pre-synaptic neuronal compartments. The results showed that clonidine increased citrate synthase, cytochrome oxidase and glutamate–oxaloacetate transaminase activities of FM. In LM, citrate synthase activity was decreased, while cytochrome oxidase and glutamate–oxaloacetate transaminase activities were increased; on the contrary, citrate synthase, cytochrome oxidase and glutamate dehydrogenase were all decreased in HM. Therefore, clonidine exerted different effects with respect to brain mitochondria, coherently with the in vivo energy requirements of each synaptic compartment: the drug increased energy-linked enzyme activities in post-synaptic compartment, while the metabolic variations were complex in the pre-synaptic one, being enzyme activities heterogeneously modified in LM and decreased in HM. This study highlights the relationships existing between the clonidine-induced neuroreceptorial effects and the energy metabolism in pre- and post- synaptic bioenergetics.Keywords
Funding Information
- Catholic Universitary Center (Centro Universitario Cattolico) - CEI
This publication has 98 references indexed in Scilit:
- Effect of Clonidine (an Antihypertensive Drug) Treatment on Oxidative Stress Markers in the Heart of Spontaneously Hypertensive RatsOxidative Medicine and Cellular Longevity, 2013
- Effect of CDP-choline on age-dependent modifications of energy- and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortexNeurochemistry International, 2012
- A pathophysiological framework of hippocampal dysfunction in ageing and diseaseNature Reviews Neuroscience, 2011
- Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressureJournal of Human Hypertension, 2011
- CYP2D6 Mediates 4-Hydroxylation of Clonidine In Vitro: Implication for Pregnancy-Induced Changes in Clonidine ClearanceDrug Metabolism and Disposition, 2010
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicityProceedings of the National Academy of Sciences, 2010
- Clonidine improves attentional and memory components of delayed response performance in a model of early ParkinsonismBehavioural Brain Research, 2010
- The Effects of Clonidine on Discrete-Trial Delayed Spatial Alternation in Two Rat Models of Memory LossNeuropsychopharmacology, 2007
- Alpha-2 adrenergic activation inhibits forskolin-stimulated adenylate cyclase activity and lipolysis in human adipocytesLife Sciences, 1982
- Tissue pharmacokinetics of clonidine in ratsJournal of Pharmacokinetics and Biopharmaceutics, 1982